Product Information
MAVYRET 100-40 MG TABLET is a brand product labeled by AbbVie Inc., priced at $153.0541 per EA under NDC 00074262504. Its NADAC has been published 39 times since Oct 1, 2025.
Strength
100; 40 mg/1; mg/1
Manufacturer
AbbVie Inc.NDC
00074262504
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
GLECAPREVIR; PIBRENTASVIRApproval Type
New Drug (NDA)
FDA Application
NDA209394On Market Since
8/3/2017
Pharmacological Classes
Price Statistics
The NADAC for MAVYRET 100-40 MG TABLET has been published 39 times since Oct 1, 2025, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $153.0541 per EA |
|---|---|
| All-time high | $153.0769 (Jun 10, 2026) |
| All-time low | $152.8048 (Oct 22, 2025) |
| 52-week high | $153.0769 |
| 52-week low | $152.8048 |
| Median price | $152.8849 |
| Average price | $152.9222 |
| Largest weekly change | +0.2% (May 20, 2026) |
| Weeks tracked | 39 |
| Tracking since | Oct 1, 2025 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of MAVYRET 100-40 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for MAVYRET 100-40 MG TABLET, manufactured by AbbVie Inc., is $153.0541 per EA (NDC 00074262504), effective Jun 24, 2026.
How has the price of MAVYRET 100-40 MG TABLET changed over time?
Over the history we have for it, the NADAC for MAVYRET 100-40 MG TABLET has held within roughly two percent of its current level. It has been tracked across 39 weekly CMS publications since Oct 1, 2025.
What are the highest and lowest recorded NADAC prices for MAVYRET 100-40 MG TABLET?
Since Oct 1, 2025, the NADAC for MAVYRET 100-40 MG TABLET has ranged from a low of $152.8048 (Oct 22, 2025) to a high of $153.0769 (Jun 10, 2026), with a median of $152.8849 per EA.
Are there cheaper alternatives to MAVYRET 100-40 MG TABLET?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as MAVYRET 100-40 MG TABLET, but none are currently priced below it.
Who manufactures MAVYRET 100-40 MG TABLET?
MAVYRET 100-40 MG TABLET (NDC 00074262504) is labeled by AbbVie Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification